[HTML][HTML] Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals
Patients with diabetes are at risk for liver disorders including glycogen hepatopathy, non-
alcoholic fatty liver disease, cirrhosis, and hepatic fibrosis. The pathophysiological …
alcoholic fatty liver disease, cirrhosis, and hepatic fibrosis. The pathophysiological …
Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals
L Mobasheri, M Ahadi, AB Namdar… - Biomedicine & … - pubmed.ncbi.nlm.nih.gov
Patients with diabetes are at risk for liver disorders including glycogen hepatopathy, non-
alcoholic fatty liver disease, cirrhosis, and hepatic fibrosis. The pathophysiological …
alcoholic fatty liver disease, cirrhosis, and hepatic fibrosis. The pathophysiological …
Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals.
L Mobasheri, M Ahadi, MS Alavi… - Biomedicine & …, 2023 - europepmc.org
Patients with diabetes are at risk for liver disorders including glycogen hepatopathy, non-
alcoholic fatty liver disease, cirrhosis, and hepatic fibrosis. The pathophysiological …
alcoholic fatty liver disease, cirrhosis, and hepatic fibrosis. The pathophysiological …